Immunologist Anna-Lena Spetz is leading the “Fight–nCoV” project at Stockholm University. Her team has together with researchers from Germany, Denmark and France been granted 2.8 million euros from the EU to develop an antiviral treatment for COVID-19. One of the goals is to develop a nasal spray to reduce viral levels in mucous membranes.